SCHEMBL1619956

SCHEMBL1619956

Fc1ccc(-n2nc3ccccc3n2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.67
HPGD P15428 1/20 0.67
NPC1 O15118 10/20 0.61
RAB9A P51151 10/20 0.61
HTT P42858 1/20 0.57
MEN1 O00255 6/20 0.53
KMT2A Q03164 6/20 0.53
MAPT P10636 6/20 0.46
RECQL P46063 1/20 0.46
ALDH1A1 P00352 2/20 0.46
STAT1 P42224 1/20 0.46
CASP3 P42574 1/20 0.45
SENP8 Q96LD8 1/20 0.45
SENP7 Q9BQF6 1/20 0.45
SENP6 Q9GZR1 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
LMNA P02545 2/20 0.43
POLB P06746 2/20 0.43
TP53 P04637 1/20 0.40
GRIA1 P42261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22688036 0.89 KDM4E (0.53) KDM4EHPGDNPC1RAB9AHTT
SCHEMBL22686631 0.89 KDM4E (0.53) KDM4EHPGDNPC1RAB9AHTT
SCHEMBL459011 0.80 KDM4E (1.00) KDM4EHPGDNPC1RAB9AHTT
SCHEMBL19794402 0.77 KDM4E (0.67) KDM4EHPGDNPC1RAB9AHTT
SCHEMBL5537671 0.77 KDM4E (0.67) KDM4EHPGDNPC1RAB9AHTT
SCHEMBL19993879 0.77 KDM4E (0.67) KDM4EHPGDNPC1RAB9AHTT
SCHEMBL2670040 0.77 KDM4E (0.67) KDM4EHPGDNPC1RAB9AHTT
SCHEMBL8995917 0.77 KDM4E (0.67) KDM4EHPGDNPC1RAB9AHTT
SCHEMBL28395544 0.77 KDM4E (0.74) KDM4EHPGDNPC1RAB9AHTT
SCHEMBL11542701 0.77 KDM4E (0.67) KDM4EHPGDNPC1RAB9AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115335488-A Boron-containing cyclic luminescent compound and color conversion film comprising the same 日东电工株式会社 2022-11-11 CN disclosed
WO-2021188762-A1 BORON-CONTAINING CYCLIC EMISSIVE COMPOUNDS AND COLOR CONVERSION FILM CONTAINING THE SAME NITTO DENKO CORPORATION (JP) 2021-09-23 WO disclosed
WO-2021188762-A1 BORON-CONTAINING CYCLIC EMISSIVE COMPOUNDS AND COLOR CONVERSION FILM CONTAINING THE SAME NITTO DENKO CORPORATION (JP) 2021-09-23 WO disclosed
EP-1966343-B1 ELECTROLUMINESCENT METAL COMPLEXES WITH TRIAZOLES UDC IRELAND LTD (IE) 2017-04-19 EP disclosed
EP-1966343-B1 ELECTROLUMINESCENT METAL COMPLEXES WITH TRIAZOLES UDC IRELAND LTD (IE) 2017-04-19 EP disclosed
CN-101346451-B Electroluminescent metal complexes of triazoles CIBA HOLDING INC 2013-09-18 CN disclosed
US-7928242-B2 Electroluminescent metal complexes with triazoles BASF SE (DE) 2011-04-19 US disclosed
US-7928242-B2 Electroluminescent metal complexes with triazoles BASF SE (DE) 2011-04-19 US disclosed
US-7928242-B2 Electroluminescent metal complexes with triazoles BASF SE (DE) 2011-04-19 US disclosed
US-20100048660-A1 TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY BIOMARIN IGA LIMITED (BS) 2010-02-25 US disclosed
US-20090062560-A1 Electroluminescent Metal Complexes With Triazoles CIBA CORPORATION (US) 2009-03-05 US disclosed
US-20090062560-A1 Electroluminescent Metal Complexes With Triazoles CIBA CORPORATION (US) 2009-03-05 US disclosed
US-20090062560-A1 Electroluminescent Metal Complexes With Triazoles CIBA CORPORATION (US) 2009-03-05 US disclosed
CN-101346451-A Electroluminescent metal complexes of triazoles CIBA SC HOLDING AG (CH) 2009-01-14 CN disclosed
EP-1966343-A1 ELECTROLUMINESCENT METAL COMPLEXES WITH TRIAZOLES Ciba SC Holding AG (CH) 2008-09-10 EP disclosed
WO-2007074093-A1 ELECTROLUMINESCENT METAL COMPLEXES WITH TRIAZOLES CIBA HOLDING INC. (CH) 2007-07-05 WO disclosed
WO-2007074093-A1 ELECTROLUMINESCENT METAL COMPLEXES WITH TRIAZOLES CIBA HOLDING INC. (CH) 2007-07-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048660-A1 TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY SMN1; SMN2, CPT1B, GYS1 KDM4E 3777/4885HPGD 2220/4885NPC1 2950/4885
US-20090062560-A1 Electroluminescent Metal Complexes With Triazoles OCIAD1, OCIAD2, CCND3 KDM4E 4281/4885HPGD 1163/4885NPC1 4252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.